Clinical Trials on Atrial Fibrillation Non-Rheumatic

Total 4349 results

Boston Scientific Japan K.K.

Completed

A Study to Evaluate the Safety and Effectiveness of the Left Atrial Appendage Closure Therapy Using BSJ003W (SALUTE)

Atrial Fibrillation Non-Rheumatic

Japan
Append Medical Ltd.

Recruiting

Applause Study I - Append System Early Feasibility Study (Applause)

Non Valvular Atrial Fibrillation

United States
Prince of Wales Hospital, Shatin, Hong Kong
Lifetech Scientific (Shenzhen) Co., Ltd.

Not yet recruiting

LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation (LAmbre2)

Non Valvular Atrial Fibrillation
Cardioangiologisches Centrum Bethanien

Recruiting

REal-world Valued Outcomes of a noveL Balloon-in-basket pUlsed Field ablaTION Catheter for Atrial Fibrillation RegistrY (REVOLUTIONARY)

Symptomatic Atrial Fibrillation | Treatment of Atrial Fibrilation

Germany
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients

Non-valvular Atrial Fibrillation (NVAF)

Hong Kong
Boston Scientific Corporation

Recruiting

WATCHMAN FLX Pro European Registry

Left Atrial Appendage Closure | Non-valvular Atrial Fibrillation (AF)

Spain, Germany, Denmark, Switzerland, Italy
Xu Liu
Shanghai Chest Hospital, Shanghai Jiao Tong University School Of Medicine

Active, not recruiting

Pulsed-Field Ablation With/Without Electrogram Mapping (PEAK-AF)

Non-paroxysmal Atrial Fibrillation

China, United States
Boston Scientific Corporation

Completed

Watchman FLX Pro CT Pilot Study

Non-valvular Atrial Fibrillation (AF)

Denmark
Nippon Medical School
Daiichi Sankyo Co., Ltd.

Active, not recruiting

STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study (STABLED)

Ischemic Stroke | Atrial Fibrillation Non-Rheumatic

Japan
Universitair Ziekenhuis Brussel

Completed

Pulsed ElectRic FiEld Versus Cryoballoon for PAF (PERFECT-PAF)

Cardiac Arrhythmia | Paroxysmal Atrial Fibrillation (PAF) | Atril Fibrillation

Belgium, Italy, Croatia, Greece, Poland
Shanghai Zhongshan Hospital
Changhai Hospital; Ruijin Hospital; Xinhua Hospital, Shanghai Jiao Tong University... and other collaborators

Not yet recruiting

A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke (AnchorMan-NVAF)

Non-valvular Atrial Fibrillation (NVAF) | High Risk of Stroke
Barts & The London NHS Trust
AtriCure, Inc.

Recruiting

Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation (CLIP-AF)

Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; Fibrillation

United Kingdom
Icahn School of Medicine at Mount Sinai
Bristol-Myers Squibb

Completed

Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry

Non-valvular Atrial Fibrillation

United States
Nedim Tojaga
Karola Jørgensens Foundation and Foundation for Cardiology in Southwest Denmark... and other collaborators

Recruiting

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion (BIO-AF)

Stroke | Thrombosis | Atrial Fibrillation New Onset | Atrial Fibrillation (AF) | Stroke (in Patients With Atrial Fibrillation) | Atrial Fibrillation (Prevention of Stroke) | Non Valvular Atrial Fibrillation

Denmark
Cardia Inc.

Unknown

Canadian Left Atrial Appendage Closure Study (CLASS)

Non-Valvular Atrial Fibrillation | Left Atrial Appendage

Canada
Scripps Health
Daiichi Sankyo, Inc.

Unknown

A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure

Non-Valvular Atrial Fibrillation | Left Atrial Appendage Closure

United States
Abbott Medical Devices

Terminated

Amplatzer Amulet China Post Market Study (PMS)

Non-Valvular Atrial Fibrillation

China
Conformal Medical, Inc

Completed

The Conformal Prague Study

Non-valvular Atrial Fibrillation

Czechia
University Hospital, Montpellier

Completed

Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program (MONACO)

Non-valvular Atrial Fibrillation

France
Bayer
Janssen Research & Development, LLC

Terminated

A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients. (PROTECT-AF)

Non-valvular Atrial Fibrillation

Norway
Pfizer

Completed

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation (CER3)

Non-valvular Atrial Fibrillation

Japan
China National Center for Cardiovascular Diseases

Recruiting

Bi-atrial Versus Left Atrial Ablation for Patients With Rheumatic Mitral Valve Disease and Non-paroxysmal Atrial Fibrillation

Persistent Atrial Fibrillation

China
Xijing Hospital
The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaborators

Not yet recruiting

Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology (RECORD)

Non-valvular Atrial Fibrillation

China
Daiichi Sankyo
Daiichi Sankyo (China) Holdings Co., Ltd.

Completed

Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China (ETNA-AF-CHINA)

Non-valvular Atrial Fibrillation

China
Bayer
Janssen Research & Development, LLC

Completed

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment (RITMUS-AF)

Non-valvular Atrial Fibrillation

Italy
Pfizer

Completed

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Non-valvular Atrial Fibrillation

Japan
Saint Luke's Health System
Bristol-Myers Squibb; AliveCor

Completed

Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm (BOAT OAR)

Non-valvular Atrial Fibrillation

United States
Bayer
Janssen Research & Development, LLC

Completed

Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists (ANTENNA)

Non-Valvular Atrial Fibrillation

United Kingdom
Bristol-Myers Squibb

Completed

Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN) (AEGEAN)

Non-valvular Atrial Fibrillation

Belgium, France, Italy, Spain, Switzerland, Germany, United Kingdom
Bristol-Myers Squibb
IMS Health; OXON Epidemiology

Completed

Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2 (REACT-AF2)

Non-valvular Atrial Fibrillation
Bristol-Myers Squibb

Completed

Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela

Non-Valvular Atrial Fibrillation
Biosense Webster, Inc.

Active, not recruiting

An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Non-valvular Atrial Fibrillation

United States
China National Center for Cardiovascular Diseases
Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

Non-Valvular Atrial Fibrillation

China
Conformal Medical, Inc
Yale Cardiovascular Research Group

Active, not recruiting

The CONFORMAL Early Feasibility Study

Non-valvular Atrial Fibrillation

United States
Bristol-Myers Squibb

Completed

Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation (ARISTOPHANES)

Non-Valvular Atrial Fibrillation

United States
Les Laboratoires des Médicaments Stériles

Enrolling by invitation

Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation (APIXA-Xa)

Non Valvular Atrial Fibrillation

Tunisia
Daiichi Sankyo, Inc.
Daiichi Sankyo Deutschland GmbH

Completed

Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ENCOURAGE-AF)

Non-valvular Atrial Fibrillation

Germany
Bristol-Myers Squibb

Withdrawn

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

Non-valvular Atrial Fibrillation

United States
Boston Scientific Corporation
IQVIA Pty Ltd; Premier Research Group plc

Completed

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)

Non-valvular Atrial Fibrillation

Ireland, Germany, Denmark, France, Spain, United Kingdom, Italy, Netherlands, Poland
Bristol-Myers Squibb
Pfizer

Withdrawn

Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation

Non-valvular Atrial Fibrillation
Bristol-Myers Squibb

Completed

A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Non-Valvular Atrial Fibrillation (NVAF)

Japan
Bayer
Janssen Scientific Affairs, LLC

Completed

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Non-valvular Atrial Fibrillation (NVAF)

Japan
HK inno.N Corporation

Active, not recruiting

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

Non-valvular Atrial Fibrillation (NVAF)

Korea, Republic of
Bristol-Myers Squibb

Withdrawn

Early Post-marketing Study of Eliquis (Apixaban)

Non-valvular Atrial Fibrillation (NVAF)

Mexico
Centre Hospitalier Universitaire, Amiens
Clinique Victor Pauchet

Recruiting

Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch (THO-FA-WATCH)

Thoracic Surgery | Postoperative Atrial Fibrillation | Cardiovascular Prognosis | Randomized Trial | Smartwatches | Rhythm Monitoring | Asymptomatic Atrial Fibrillation

France
Eclipse Medical Ltd.
KCRI; Cardiovascular Research Institute Dublin

Active, not recruiting

Evaluation of Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk (Omega)

Non-Valvular Atrial Fibrillation

Denmark, Germany, Ireland, Italy, Spain, United Kingdom
Assistance Publique - Hôpitaux de Paris

Unknown

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF) (Presage-Aco)

Non Valvular Atrial Fibrillation (nv AF)
University of Leicester

Completed

'Understanding the Electrophysiological Substrate Underlying Persistent Atrial Fibrillation Study II (USURP AF- Study II)' (USURPAF)

Persistent Atrial Fibrillation | Pulmonary Vein Isolation | Atrial Fibrillation Mechanisms | Substrate Ablation | Non-contact Mapping

United Kingdom
China National Center for Cardiovascular Diseases

Recruiting

LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.

Non-paroxysmal Atrial Fibrillation

China
Boston Scientific Corporation

Completed

Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong

Non-valvular Atrial Fibrillation

China

Clinical Trials on Atrial Fibrillation Non-Rheumatic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations